Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
NEW KITCHENAID® ESPRESSO COLLECTION FEATURING SEMI-AUTOMATIC AND FULLY-AUTOMATIC MACHINES OPENS THE DOOR TO EASY ESPRESSO MAKING
-
Windfall Bio Raises $28 Million Series A to Scale Methane Capture & Transformation Solution
-
Hotel Equities Partners with NetSuite
-
Sono-Tek Announces Preliminary Net Sales for Q4 and FY2024 and Provides Preliminary Sales Guidance for Q1 FY2025 and FY2025
-
Syncromune® Inc. Presents Positive Results from SYNC-T™ SV-102 Phase 1 Trial at AACR Annual Meeting 2024
-
Diversified Healthcare Trust First Quarter 2024 Conference Call Scheduled for Tuesday, May 7th
-
Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting
-
Charles Schwab Named Best Investing Platform Overall by U.S. News
-
Verismo Therapeutics Announces Upcoming Presentation at AACR 2024
-
Palmer Square Capital Launches European CLO Index
-
ORYZON Announces U.S. FDA Clearance of CTEP-CRADA Phase I/II Clinical Trial Sponsored by NCI for Iadademstat Plus Immune Checkpoint Inhibitors in 1L Extensive Stage Small Cell Lung Cancer
-
Infineon and Amkor Deepen Partnership and Strengthen European Supply Chain for Semiconductor Solutions
-
Lonestar Data Holdings Announces Freedom, its Second Lunar Data Center mission to the Moon in 2024
-
VSEAT's noseless bike seat to appear on ABC's Shark Tank on April 12
-
CivicScience and Basis Technologies Power Political Ad Targeting and Measurement in First-to-Market Partnership
-
McCune Law Group Files Employee Rights Lawsuit Against Amazon
-
Treatment.com AI welcomes the Federal Government's announcement of a plan to fund $2.4 billion in its upcoming budget towards Artificial Intelligence (AI) Adoption
-
Natera Announces New Data From Two Studies Extending the Clinical Validation of Its Prospera™ Heart dd-cfDNA Test for Heart Transplant Recipients
-
Fortune Minerals Announces Arrival of Samples at SGS Canada in Lakefield, Ontario for Metallurgical Testing
-
Neon One Unveils "The Recurring Giving Report: Data-Backed Insights for Sustainable Generosity" - Empowering Nonprofits with the Blueprint for Sustainable Revenue
-
First Federal Savings Bank and ICBA Share Money Management Tips to Help Americans Be More Financially Resilient
-
Hinge Bio Presents Preclinical Data from its GEM-DIMER Program Targeting B Cell Depletion at the American Association for Cancer Research (AACR) Annual Meeting 2024
-
Energy Vault Issues 2023 Sustainability Report
-
CCC Sets Bold Vision to Make Life Just Work for Customers and the Millions of Consumers Involved in Auto Claims, Repairs Each Year
-
Lithium South Developing High-Value Alternatives in Lithium Production
-
Stonebranch Announces Significant Minority Investment from EMH Partners
-
Alterome Therapeutics Presents Pre-Clinical Data Supporting the Development of Lead Program, an AKT1 E17K Inhibitor
-
SeekIn Presents New OncoSeek® Data at the AACR Annual Meeting in San Diego
-
ManTech Names Barbara Haines-Parmele as Executive Vice President and General Manager of Intelligence Sector
-
SHINE Technologies, LLC Announces Submission of FDA Drug Master File for Non-Carrier-Added Lutetium-177
-
Stellar Cyber Named as a Representative Vendor in the 2024 Gartner® Market Guide for Network Detection and Response
-
Tyto Athene, an Arlington Capital Partners Portfolio Company, Bolsters Space System Capabilities Through the Acquisition of Microtel, LLC
-
Veriato Launches Next Generation Insider Risk Management Solution to Meet Today’s Organizational Cybersecurity Needs
-
Sapience Therapeutics Presents Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024
-
STEALTH BIOTHERAPEUTICS ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLICATION FOR ELAMIPRETIDE FOR THE TREATMENT OF BARTH SYNDROME
-
Evolv Technology to Release First Quarter Financial Results on May 9, 2024
-
CION Investment Corporation Schedules 2024 First Quarter Earnings Release and Conference Call
-
Softchoice Announces Date of First Quarter 2024 Results
-
OutSystems Named a Leader in G2’s Enterprise Grid Report for Low-Code Development Platforms
-
Virtium Introduces Industrial-grade High-Capacity E1.S NVMe SSD Platform With 5+ Year Availability
-
FDA Accepts Filing of New Drug Application for Nalmefene Auto-injector for the Treatment of Known or Suspected Opioid Overdose
-
Ventus Therapeutics to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference
-
Intertrust Group Rebrands to CSC Following Acquisition
-
KB Home Announces the Grand Opening of Its Newest Community in San Antonio, Texas
-
CTS Engines Secures Approval for CF6-80E1 Engine Test Cell Correlation, Sole Facility in North America Catering to Operators
-
TRIVAD Recognized by Northrop Grumman for Quality Excellence
-
Magnolia Oil & Gas Schedules Conference Call for First Quarter 2024 Results
-
Synchron Launches Patient Registry for Stentrode Brain Computer Interface
-
Vizgen Expands Single-Cell Spatial Transcriptomics Offering with Introduction of MERSCOPE® Ultra Platform and MERFISH 2.0 Chemistry at AACR 2024
-
New Oracle AI-powered Cloud Service Helps Banks Mitigate Anti-Money-Laundering Risks

